Reddit Posts
💰Good morning! #premarket #watchlist 05/23 $INO -Present at Jefferies 2022 Healthcare Conference, $EVOK -Analysis Reveals a Lower Risk of Tardive Dyskinesia (TD) with Metoclopramide than Previously Reported, $OIIM -Receipt of an Updated Preliminary Non-Binding Proposal to Acquire the Company!
💰Good morning! #premarket #watchlist 05/23 $SIGA -Zacks Analyst Blog Highlights SIGA Technologies, $INO -Present at Jefferies 2022 Healthcare Conference, $EVOK -Analysis Reveals a Lower Risk of Tardive Dyskinesia (TD) with Metoclopramide than Previously Reported, $VMW -Broadcom Might Want to Buy!
💰Good morning! #premarket #watchlist 05/23 $SIGA -Zacks Analyst Blog Highlights SIGA Technologies, $INO -Present at Jefferies 2022 Healthcare Conference, $EVOK -Analysis Reveals a Lower Risk of Tardive Dyskinesia (TD) with Metoclopramide than Previously Reported, $VMW -Broadcom Might Want to Buy!
💰Good morning! #premarket #watchlist 05/23 $SIGA -Zacks Analyst Blog Highlights SIGA Technologies, $INO -Present at Jefferies 2022 Healthcare Conference, $EVOK -Analysis Reveals a Lower Risk of Tardive Dyskinesia (TD) with Metoclopramide than Previously Reported, $VMW -Broadcom Might Want to Buy!
I just got a 100K HELOC with a 3.99% interest rate. Let's YOLO.
$EVOK steady climb with more short interest today. Higher buying pressure than sell. Buyout rumours price target $10-$20. Large accumulation last week and more this week.
Mentions
im just going to take a wild guess and assume todays lounge will be people chucking their money at EVOK, make a modest 30% gain before it crabs tomorrow; birthing a new gen of bag holders.
EVOK went almost all in around 3.12s not in anymore not financial advice
(EVOK) said Monday that a study showed that its nasal spray, Gimoti, used to treat patients with diabetic gastroparesis who were concurrently using GLP-1, showed reduced healthcare resource utilization compared with oral Metoclopramide. The study showed that all-cause emergency department visits decreased by 55%, while diabetic gastroparesis-related emergency department visits reduced by 28% in patients with a prior GLP-1 history, the company said. It added that all-cause and diabetic gastroparesis-related emergency departments were 91% and 89% lower, respectively, in patients taking GLP-1.
Waiting for a pullback on EVOK
I bought a drug company, still cheap. EVOK, on a nice ride so far for this month.
Thoughts on EVOK for a potential buyout?
$EVOK had big jump yesterday too.
$EVOK huge short ratio and top gainer on news. FDA clearance. Let's squeeze.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: EVOK. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: EVOK. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.
Eyes on heavy shorted $EVOK today
I am betting on 2 EVOK - developed and patented a new drug BFRI - not really a penny stock bit as close as you can get.
$EVOK hasbeen sold to oblivion. Oversold. FDA approved drug.
Bought some EVOK maybe I’ll make enough soon to dump earnings on more amc and gme
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: EVOK. Message /u/zjz if they're above 1.25 billion-ish market cap and not related to crypto/pennies/OTC/SPACs.
Hype on SNDL but high price target is EVOK.
EVOK has like a $13 price target but low volume. Don’t know of a catalyst but I’m long on it
EVOK has very low average volume. In your opinion why will it run before the shareholder meeting on the 5th?
A play that has been really interesting to me is holding EVOK until May 5th. They’re at an enticing price at the moment and could possibly make a $1 run in the next week. What plays do you guys have going on?
I sold AMC for plus 50% yesterday for the second time, but I really don't have any plays in mind for the funds yet. Holding ZOM, TAKOF, CCL , EVOK, and OCGN. Probably bag holding ASRT and ETFM.
Came looking to see what people thought about EVOK earnings. Found this gem...wooooof
MRKR, EVOK, and ACAD are on sale, buy low right??
Morgan Stanley reports 442.42% increase in ownership of EVOK / Evoke Pharma, Inc. 2021-02-16 - Morgan Stanley has filed a 13F-HR form disclosing ownership of 504,013 shares of Evoke Pharma, Inc. (US:EVOK) with total holdings valued at $1,300,000 USD as of 2020-12-31. Morgan Stanley had filed a previous 13F-HR on 2020-11-13 disclosing 92,920 shares of Evoke Pharma, Inc. at a value of $436,000 USD. This represents a change in shares of 442.42 percent and a change in value of 198.17 percent during the quarter.